Article PDF
Avoid common mistakes on your manuscript.
References
Ammann A. J., Ashman R. F., Buckley R. H., Hardie W. R., Krantmann H. J., Nelson J., Ochs H., Stiehm E. R., Tiller T., Wara D. W., Wedgwood R.: Use of intravenous γ-globulin in antibody immunodeficiency: results of a multicenter controlled trial—Clin. Immunol. Immunopath.22, 60, 1982.
Barnes G. L., Doyle L. W., Hewson P. H., Knoghes A. M. L., MacLellan J. A., Kitchen W. H., Bishop R. F.: A randomised trial of oral gammaglobulin in low birth weight infants infected with rotavirus—Lanceti, 1371, 1982.
Beck O. E., Kaiser P. E.: Distribution of human IgG subclasses in commercial intravenous immunoglobulin preparations. A rate nephelometric method—Vox Sang. (Basel)41, 79, 1981.
Berger M., Cupps T. R., Fauci A. S.: Immunoglobulin replacement therapy by slow subcutaneous infusion—Ann. intern. Med..93, 55, 1980.
Blum P. M., Phelps D. L., Ank B. J., Krantmann H. J., Stiehm E. R.: Survival of oral human immune serum globulin in the gastrointestinal tract of low birth weight infants—Pediat. Res.15, 1256, 1981.
Bruton O. C.: Agammaglobulinemia—Pediatrics9, 722, 1952.
Cocozza R., Triggiani M., Dammacco F.: Esperienze clinico-immunologiche con un nuovo preparato di immunoglobuline umane arricchite in IgA—Folia allerg. immunol. clin.26, 151, 1979.
Cohn J. E., Strong L. E., Hughes W. L., Mulford D. J., Ashworth J. N., Melin M., Taylor A. C.: Preparation and properties of serum and plasma proteins—J. Amer. chem. Soc.68, 459, 1946.
Dammacco F., Miclietta A., Pantaleo G., Bonomo L.: La terapia con immunoglobuline nella pratica clinica: indicazioni, applicazioni e limiti. In Atti 2° Simp. internaz. Microbiol. clin. Roma, 7–8 novembre 1980. Palombi Editori, Roma, 1981; p. 147.
Dammacco F., Perosa F., Campobasso N.: Esperienze cliniche con un nuovo preparato di immunoglobuline per via endovenosa. (In preparazione).
Dammacco F., Tursi A., Lucivero G., Bonomo L.: Selective IgA deficiency: a heterogeneous immunodeficiency syndrome—La Ricerca Clin. Lab.6 (Suppl. 3), 45, 1976.
Delacroix D. L., Reynaert M., Pauwels S., Geubel A. P., Vaerman J.-P.: High serum levels of secretory IgA in liver disease. Possible liver origin of the circulating secretory component.—Digest. Dis. Sci.27, 333, 1982.
Delire, M., Masson P. L.: The detection of circulating immune complexes in children with recurrent infections and their treatment with human immunoglobulins—Clin. exp. Immunol.29, 385, 1977.
Delire M., Petit B., Fiasse L., Masson P. L.: The therapeutic efficacy of human immunoglobulins as a function of theirin vitro antibody activity toward circulating antigens in children with recurrent infections of the upper respiratory tract—J. clin. lab. Immunol.4, 159, 1980.
Durandy A., Fischer A., Griscelli C.: Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy—J. clin. Invest.67, 867, 1981.
Fehr J., Hofmann V., Kappeler U.: Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma-globulin—New Engl. J. Med.306, 1254, 1982.
Gislason D., Hanson L. A., Kjellman H., Ljunggren C., Malmberg R.: Intravenous gamma-globulin infusions in patients with hypo-gamma-globulinemia. Prevention of adverse reactions with corticosteroids—Vox Sang. (Basel)34, 143, 1978.
Hitzig W. H.: Therapeutische Anwendung von Immunoglobulinen bei Kindern—Blut40, 215, 1980.
Hitzig W. H., Müntener U.: Conventional immunoglobulin therapy—Birth Defects (orig. Article ser.)11, 339, 1975.
Imbach P., Barandun S., D'Apuzzo V., Baumcartner C., Hirt A., Morell A., Rossi E., Schöni M., Vest M., Wagner H. P.: High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhoodLancet i, 1228, 1981.
International Forum: Which is the factual basis, in theory and clinical practice, for the use of intravenous gammaglobulin in treatment of severe bacterial infections?.—Vox Sang. (Basel)37, 116, 1979.
Janeway C. A., Rosen F. S.: The gammaglobulins. IV. Therapeutic uses of gammaglobulins. New Engl. J. Med.275, 826, 1966.
John, T. J., Ninan G. T., Rajagopalan M. S., John F., Flewett T. H., Francis D. P., Zuckerman A. J.: Epidemic hepatitis B caused by commercial human immunoglobulin— Lanceti, 1074, 1979.
Kinkelstein M. S., Uhr J. W.: Specific inhibition of antibody function by passively administered 19S and 7S antibody—Science146, 67, 1964.
Kistler P., Nitschmann H.: Large scale production of human plasma fractions—Vox Sang. (Basel)7, 414, 1962.
Maghavy D. B., Cassidy J. T., Tubergen D. G., Petty R. E., Chrisholm R., McCall K.: Intravenous gammaglobulin in the management of patients with hypogammaglobulinemia— J. All. clin. Immunol.61, 378, 1978.
Masuho Y., Tomibe K., Watanabe T., Fukumoto Y.: Development of an intravenous gammaglobulin with Fc activities. II. Reconversion of S-sulfonated human gammaglobulin into the original gammaglobulin—Vox Sang. (Basel)32, 290, 1977.
Memorandum from an IUIS/WHO Meeting: Appropriate uses of human immunoglobulin in clinical practice—Bull. Wld Hlth Org.60, 43, 1982.
Morell A., Schürch B., Ryser D., Hofer F., Skvaril F., Barandun S.:In vivo behaviour of gammaglobulin preparations—Vox Sang. (Basel)38, 272, 1980.
Nolte M. T., Pirofsky B., Gerritz G. A., Golding B.: Intravenous immunoglobulin therapy for antibody deficiency—Clin. exp. Immunol.36, 237, 1979.
Ochs H. D.: Prophylactic treatment of immunodeficiency syndromes with intravenous gammaglobulin—Vox Sang. (Basel)37, 126, 1979.
Orlans E., Peppard J., Reynolds J., Hall J. G.: Rapid active transport of immunoglobulin A from blood to bile—J. exp. Med.147, 588, 1978.
Pollack S., Cunningham-Rundles C., Smithwick E. M., Barandun S., Good R. A.: High-dose intravenous gammaglobulin for autoimmune neutropenia—New Engl. J. Med.307, 253, 1982.
Reerink H. W., Reerink-Brongers E. E., Lafeber-Schut B. J. T., Kalshoven-Benschop J. Brummelhuis H. G. J.: Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulin—Lancetii, 436, 1979.
Römer J., Morgenthaler J. J., Scherz R., Skvaril F.: Characterization of various immunoglobulin preparations for intravenous application. I. Protein composition and antibody content—Vox Sang. (Basel)42, 62, 1982.
Römer J., Späth P. J., Skvaril F., Nydegger U. E.: Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding toStaphylococcus protein A—Vox Sang. (Basel)42, 74, 1982.
Schroeder D. D., Tankersley D. L., Lundblad J. L.: A new preparation of modified immune serum globulin (human) suitable for intravenous administration. I. Standardization of the reduction and alkylation reaction—Vox Sang. (Basel)40, 373, 1981.
Schroeder D. D., Tankersley D. L., Lundblad J. L.: A new preparation of modified immune serum globulin (human) suitable for intravenous administration. II. Functional characterization.— Vox Sang. (Basel)40, 383, 1981.
Schultze H. E., Schwick H. G.: Über neue Möglichkeiten intravenöser Gammaglobulin-Applikation.— Dtsch. med. Wschr.87, 1643, 1962.
Schwenk H. U., Baenkler H. W.: Effect of gammaglobulin injection on circulating immune complexes in various diseases—Europ. J. Pediat.131, 43, 1979.
Schwick H. G.: A survey of the production of plasma derivatives for clinical use—Vox Sang. (Basel)23, 82, 1972.
Schwick H. G., Fischer J., Geiger H.: Human IgA and IgM-globulins for clinical use— Progr. immunobiol. Standard.4, 86, 1970.
Skvaril F., Probst M., Audran R., Steinbuch M.: Distribution of IgG subclasses in commercial and some experimental gammaglobulin preparations—Vox Sang. (Basel)32, 335, 1977.
Skvaril F., Roth-Wicky B., Barandun S.: IgG subclasses in human gammaglobulin preparations for intravenous use and their reactivity withStaphylococcus protein A—Vox Sang. (Basel)38, 147, 1980.
Soothill J. F.: Reactions to immunoglobulin. In: Hypogammaglobulinaemia in the United Kingdom—MRC Spec. Rep. Ser. No. 310, 1971.
Tomasi T. B. Jr.,Bienenstock J.: Secretory immunoglobulins—Advanc. Immunol.9, 1, 1968.
Ugazio A. G., Duse M., Re R., Mangili G., Burgio G. R.: Subcutaneous infusion of gammaglobulin in management of agammaglobulinaemia—Lanceti, 226, 1982.
Vyas G. N., Fudenberg H. H.: Isoimmune anti-IgA causing anaphylactoid transfusion treactions.— New Engl. J. Med.280, 1973, 1969.
Waldmann T. A., Strober W.: Metabolism of immunoglobulins—Progr. Allergy13, 1, 1969.
Webster A. D. B., Loewi G., Dourmashkin R. D., Golding D. N., Ward D. J., Asherson G. L.: Polyarthritis in adults with hypogammaglobulinaemia and its rapid response to immunoglobulin treatment—Brit. med. J.i, 1314, 1976.
WHO: The role of immune complexes in disease. Report of a WHO scientific group. Technical Report Series 606. World Health Organization, Geneva, 1977.
Winkelhake J. L.: Immunoglobulin structure and effector functions—Immunochemistry15, 695, 1978.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dammacco, F., Campobasso, N. & Perosa, F. Human immunoglobulins in therapy. Rationale and clinical applications. La Ricerca Clin. Lab. 13, 183–202 (1983). https://doi.org/10.1007/BF02904833
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02904833